VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V -
XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary,
Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health
Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin
cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce
high-quality cannabis.
Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of
luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience.
Robinsons products have consistently ranked the highest in terms of cannabinoid content, terpene content and overall quality when
independently tested against 5,000 products supplied by various growers licenced in accordance with Canadian cannabis
regulations.
“We are thrilled to have achieved this major milestone,” says Andrew Robinson. “Our goal is to produce the best
cannabis we can, for cannabis connoisseurs like ourselves. The licences will allow us to start production and take steps toward
delivering a consistent final product focused on taste, smell, and potency.”
Hugo Alves, President of Auxly said: “This is a big milestone for one of our key subsidiaries and member of the
Auxly family. We know that Andrew and his team are going to produce some of the best cannabis flower available in Canada and we
can’t wait to share it with Canadian consumers. Robinsons is all about an unwavering commitment to quality. We hope to show
cannabis connoisseurs, who to date have been generally disappointed with the flower offerings in the market, that passionate
artisans operating in the regulated industry can produce an incredible product that reflects their pride and craftsmanship.”
Auxly expects that Robinsons’ premier products will be available for sale in the fourth quarter of this year,
subject to receipt of sales authorization from Health Canada. With a focus on quality, Robinsons plans to release a
limited amount of product to the market of approximately 1,100kg per year.
ON BEHALF OF THE BOARD
"Chuck Rifici" Chairman & CEO
About Auxly Cannabis Group Inc. (TSX.V: XLY)
Auxly is a vertically integrated cannabis company with diverse operations across Canada and Uruguay and a
platform spanning the entire cannabis value chain. The Company relies upon its diversified cannabis cultivation platform, its
leading research and development infrastructure, its domestic and international distribution platform and its experienced team of
industry leaders and strategic partners in order to serve an evolving global cannabis market.
Investor Relations:
For more information about investing in Auxly Cannabis Group, please visit: http://www.auxly.com or contact our Investor Relations Team:
Email: IR@auxly.com
Phone: 1.833.695.2414
Stay Connected:
Follow up on Twitter @Auxlygroup
Media Enquiries (only):
For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs
Email: sarah@auxly.com
Phone: 613.230.5869
Notice Regarding Forward Looking Information:
This news release contains certain "forward-looking information" within the meaning of applicable Canadian
securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that
certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing
the conclusions or making the projections contained in the forward-looking information throughout this news release.
Forward-looking information includes, but is not limited to: expectations of future growing capacity at the Robinsons facility;
political change, future legislative and regulatory developments involving cannabis; and competition and other risks affecting the
Company in particular and the cannabis industry generally.
A number of factors could cause actual results to differ materially from a conclusion, forecast or projection
contained in the forward-looking information in this release including, but not limited to, whether: Robinsons is able to maintain
the Cultivation License and obtain a sales licence; Robinsons can obtain all necessary governmental and regulatory permits and
approvals for the facility, and whether such permits and approvals can be obtained in a timely manner; and general economic,
financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors
are disclosed in the revised annual information form of the Company for the financial year ended December 31, 2017 dated May 24,
2018.
New factors emerge from time to time, and it is not possible for management to predict all of those factors or
to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking
information in this release is based on information currently available and what management believes are reasonable assumptions.
Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain
forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by the Company.
The purpose of forward-looking information is to provide the reader with a description of management's expectations, and such
forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on
forward-looking information contained in this release.
The forward-looking information contained in this release is expressly qualified by the foregoing cautionary
statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does
not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after
the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future
events or results, or otherwise.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
